295 related articles for article (PubMed ID: 21605808)
1. Clinical features and practical diagnosis of bullous pemphigoid.
Schmidt E; della Torre R; Borradori L
Dermatol Clin; 2011 Jul; 29(3):427-38, viii-ix. PubMed ID: 21605808
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and practical diagnosis of bullous pemphigoid.
Schmidt E; della Torre R; Borradori L
Immunol Allergy Clin North Am; 2012 May; 32(2):217-32, v. PubMed ID: 22560135
[TBL] [Abstract][Full Text] [Related]
3. Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis.
Yayli S; Pelivani N; Beltraminelli H; Wirthmüller U; Beleznay Z; Horn M; Borradori L
Br J Dermatol; 2011 Nov; 165(5):1133-7. PubMed ID: 21711326
[TBL] [Abstract][Full Text] [Related]
4. Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.
Bernard P; Antonicelli F
Am J Clin Dermatol; 2017 Aug; 18(4):513-528. PubMed ID: 28247089
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
[TBL] [Abstract][Full Text] [Related]
6. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
[TBL] [Abstract][Full Text] [Related]
7. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.
Feng S; Wu Q; Jin P; Lin L; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Mar; 47(3):225-8. PubMed ID: 18289320
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
10. Ecthyma-gangrenosum-like bullous pemphigoid.
Geiss Steiner J; Trüeb RM; Kerl K; Mühleisen B; French LE; Hofbauer GF
Dermatology; 2010; 221(2):142-8. PubMed ID: 20689254
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
[TBL] [Abstract][Full Text] [Related]
12. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
[TBL] [Abstract][Full Text] [Related]
13. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients.
Bernard P; Bedane C; Bonnetblanc JM
Br J Dermatol; 1997 May; 136(5):694-8. PubMed ID: 9205501
[TBL] [Abstract][Full Text] [Related]
14. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.
Dilling A; Rose C; Hashimoto T; Zillikens D; Shimanovich I
J Dermatol; 2007 Jan; 34(1):1-8. PubMed ID: 17204094
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of immunoblotting in the diagnosis of blistering skin diseases].
Kiss M; Husz S; Dobozy A
Orv Hetil; 1994 Oct; 135(40):2197-9. PubMed ID: 7970633
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
[TBL] [Abstract][Full Text] [Related]
17. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
18. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
19. Clinical variations in bullous pemphigoid with respect to early symptoms.
Asbrink E; Hovmark A
Acta Derm Venereol; 1981; 61(5):417-21. PubMed ID: 6172930
[TBL] [Abstract][Full Text] [Related]
20. Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study.
Sernicola A; Russo I; Saponeri A; Alaibac M
Medicine (Baltimore); 2019 Feb; 98(7):e14514. PubMed ID: 30762788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
